Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

15.2%

56 terminated/withdrawn out of 368 trials

Success Rate

78.2%

-8.3% vs industry average

Late-Stage Pipeline

30 trials in Phase 3/4

Results Transparency

35%

70 of 201 completed trials have results

Key Signals

63 recruiting70 with results30 terminated26 withdrawn

Enrollment Performance

Analytics

N/A

150(55.8%)

Phase 2

55(20.4%)

Phase 1

28(10.4%)

Phase 3

18(6.7%)

Phase 4

12(4.5%)

Early Phase 1

6(2.2%)

269Total

N/A(150)

Phase 2(55)

Phase 1(28)

Phase 3(18)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (368)

Showing 20 of 368 trials

NCT05852392Not ApplicableRecruiting

Comparing a Team-Based Approach to Standard Well-Child Visits To Improve Preventive Care Services

Role: collaborator

NCT03769844Phase 4Completed

GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study

Role: lead

NCT06114836Not ApplicableRecruiting

GERD Infant Feeding Therapeutics Trial (GIFT Trial)

Role: lead

NCT04621279Recruiting

Cool Prime Comparative Effectiveness Study for Mild HIE

Role: collaborator

NCT05685745Recruiting

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

Role: collaborator

NCT01120353Recruiting

Childhood Cancer Survivor Study

Role: collaborator

NCT07549646Phase 2Active Not Recruiting

24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs

Role: collaborator

NCT05834049Not ApplicableWithdrawn

Virtual Parental Presence on Induction of Anesthesia vs Premedication With Midazolam

Role: collaborator

NCT05887882Phase 1Suspended

Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors

Role: collaborator

NCT05233397Phase 2Recruiting

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Role: lead

NCT07543822Phase 2Active Not Recruiting

24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs

Role: collaborator

NCT05843253Phase 2Recruiting

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Role: lead

NCT04113434Completed

Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome

Role: collaborator

NCT05217615Not ApplicableCompleted

Parent Training for Parents of Toddlers Born Very Premature:

Role: collaborator

NCT04197596Phase 1Recruiting

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Role: collaborator

NCT07231705Not ApplicableRecruiting

Growth and Tolerance of Plant-based Enteral Formulas in Children Ages 12-17 Months.

Role: collaborator

NCT07035873Not ApplicableRecruiting

Pediatric Cochlear Implant Remote Programming and Assessment

Role: lead

NCT04896606Phase 1Recruiting

SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease

Role: collaborator

NCT05278208Phase 1Recruiting

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Role: lead

NCT05266001Phase 3Completed

GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS

Role: lead